Ignite Creation Date:
2024-05-06 @ 7:31 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06046014
Status:
RECRUITING
Last Update Posted:
2024-05-07
First Post:
2023-09-13
Brief Title:
Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
University of Michigan Rogel Cancer Center
Study Overview
Official Title:
Determining the Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Each year about 89500 adolescents and young adults AYAs 15-39 years old are diagnosed with cancer and up to 60 experience body image BI distress BI is largely developed in adolescence and young adulthood and has implications for self-identity and quality of life Cancer itself and its associated treatments precipitate changes to appearance as well as body sensation and function all of which can alter BI and lead to increased anxiety An in-home BI-focused expressive writing EW program offers a promising outlet for addressing BI distress and anxiety in a way that eliminates constraints of clinical time and specialist availability
There are no recommended interventions to help AYA cancer survivors cope with BI distress To address this knowledge gap the objective of this this pilot randomized-controlled trial is to determine the feasibility of a four-week BI-focused EW intervention to decrease BI distress and anxiety among AYA cancer survivors with the hypothesis that this intervention will reduce BI distress and anxiety
There are no recommended interventions to help AYA cancer survivors cope with BI distress To address this knowledge gap the objective of this this pilot randomized-controlled trial is to determine the feasibility of a four-week BI-focused EW intervention to decrease BI distress and anxiety among AYA cancer survivors with the hypothesis that this intervention will reduce BI distress and anxiety
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HUM00239179 | OTHER | University of Michigan | None |